Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction.

NCT00269607 is registered in ClinicalTrials.gov with University of Oslo as lead sponsor.

NCT NCT00269607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00269607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction.
Lead sponsor
University of Oslo
Phase
Phase 2/3
Overall status
Terminated
Start date
May 31, 2005
Completion date
December 31, 2006
Enrollment
12 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependency